Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-24 6:34 PM View:  | Corteva, Inc. (CTVA) | 26-Apr-24 | Grant | 3,100 | -- | -- | 10% 31.36K to 34.46K | |
| 25-Apr-23 4:38 PM View: | Corteva, Inc. (CTVA) | 21-Apr-23 | Grant | 2,770 | -- | -- | 10% 28.25K to 31.02K | |
| 03-May-22 4:19 PM View: | Corteva, Inc. (CTVA) | 29-Apr-22 | Grant | 2,950 | -- | -- | 12% 25.02K to 27.97K | |
| 11-May-21 5:31 PM View: | Corteva, Inc. (CTVA) | 07-May-21 | Grant | 3,480 | $48.86 | $170,033.00 | 16% 21.25K to 24.73K | (7%) |
| 30-Apr-20 4:55 PM View: | Corteva, Inc. (CTVA) | 28-Apr-20 | Grant | 6,500 | $26.19 | $170,235.00 | 45% 14.42K to 20.92K | 71% |
| 05-Feb-20 5:17 PM View: | Corteva, Inc. (CTVA) | 03-Feb-20 | Market Sale | 90 | $29.11 | $2,619.90 | (< 1%) 14.44K to 14.35K | (53%) |
| 05-Jun-19 7:03 PM View: | Corteva, Inc. (CTVA) | 03-Jun-19 | Grant | 6,860 | -- | -- | 93% 7.36K to 14.22K | |
| 26-Jun-19 7:32 PM View: | Dupont de Nemours, Inc. (DD) | 21-May-19 | Market Purchase | 270 | $31.99 | $8,637.30 | 1% 21.96K to 22.23K | < 1% |
| 18-Sep-18 4:36 PM View: | Dupont de Nemours, Inc. (DD) | 14-Sep-18 | Grant | 119 | $65.58 | $7,825.76 | < 1% 21.54K to 21.66K | (51%) |
| 19-Jun-18 5:44 PM View: | Dupont de Nemours, Inc. (DD) | 15-Jun-18 | Grant | 120 | $67.75 | $8,138.12 | < 1% 21.41K to 21.54K | (53%) |
| 26-Apr-18 10:00 PM View: | Dupont de Nemours, Inc. (DD) | 25-Apr-18 | Grant | 2,680 | -- | -- | 14% 18.74K to 21.42K | |
| 16-Mar-18 5:38 PM View: | Dupont de Nemours, Inc. (DD) | 15-Mar-18 | Grant | 104 | $67.88 | $7,080.08 | < 1% 18.63K to 18.74K | (53%) |
| 26-Jun-19 7:32 PM View: | Dupont de Nemours, Inc. (DD) | 08-Mar-18 | Market Sale | 85 | $70.31 | $5,976.35 | (< 1%) 18.72K to 18.63K | 55% |
| 19-Dec-17 5:03 PM View: | Dupont de Nemours, Inc. (DD) | 15-Dec-17 | Grant | 101 | $70.00 | $7,041.85 | < 1% 18.53K to 18.63K | (55%) |
| 08-Nov-17 4:49 PM View: | Dupont de Nemours, Inc. (DD) | 06-Nov-17 | Grant | 190 | -- | -- | 1% 18.36K to 18.55K | |
| 03-Oct-17 6:59 PM View: | Dupont de Nemours, Inc. (DD) | 29-Sep-17 | Grant | 100 | $69.23 | $6,939.94 | < 1% 18.26K to 18.36K | (54%) |
| 26-Jun-19 7:32 PM View: | Dupont de Nemours, Inc. (DD) | 18-Sep-17 | Market Purchase | 85 | $70.19 | $5,966.00 | < 1% 18.26K to 18.35K | (55%) |
| 05-Sep-17 5:49 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 31-Aug-17 | Disposition | 14,243 | -- | -- | (100%) 14.24K to 0 | |
| 14-Jun-17 4:57 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 12-Jun-17 | Grant | 57 | $82.14 | $4,661.04 | < 1% 14.19K to 14.24K | 1% |
| 25-May-17 4:37 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 24-May-17 | Grant | 1,920 | -- | -- | 16% 12.27K to 14.19K | |
| 10-Apr-17 5:09 PM View: | Bristol-Myers Squibb Co. (BMY) | 07-Apr-17 | Market Sale (Planned) | 17,000 | $53.22 | $904,791.00 | (1%) 1.19M to 1.18M | (8%) |
| 10-Apr-17 5:09 PM View: | Bristol-Myers Squibb Co. (BMY) | 06-Apr-17 | Market Sale (Planned) | 17,000 | $53.29 | $905,964.00 | (1%) 1.21M to 1.19M | (7%) |
| 04-Apr-17 7:18 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Mar-17 | Grant | 459 | $54.38 | $24,960.40 | < 1% 1.21M to 1.21M | 5% |
| 29-Mar-17 6:19 PM View: | Bristol-Myers Squibb Co. (BMY) | 28-Mar-17 | Market Sale (Planned) | 17,000 | $56.20 | $955,369.00 | (1%) 1.23M to 1.21M | (1%) |
| 29-Mar-17 6:19 PM View: | Bristol-Myers Squibb Co. (BMY) | 27-Mar-17 | Market Sale (Planned) | 17,000 | $56.14 | $954,451.00 | (1%) 1.24M to 1.23M | (1%) |
| 16-Mar-17 4:54 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 14-Mar-17 | Grant | 58 | $80.42 | $4,639.12 | < 1% 12.21K to 12.27K | 4% |
| 14-Mar-17 8:30 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-17 | Payment of Exercise | 56,993 | $58.32 | $3,323,830.00 | (4%) 1.3M to 1.24M | 2% |
| 14-Mar-17 8:30 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-17 | Option Exercise | 102,174 | -- | -- | 9% 1.2M to 1.3M | |
| 01-Feb-17 4:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 30-Jan-17 | Option Exercise | 100,000 | $27.01 | $2,701,000.00 | 9% 1.1M to 1.2M | |
| 04-Jan-17 8:20 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-16 | Grant | 427 | $58.44 | $24,953.90 | < 1% 1.1M to 1.1M | (3%) |
| 16-Dec-16 4:30 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 14-Dec-16 | Grant | 63 | $73.71 | $4,615.33 | < 1% 12.14K to 12.21K | 14% |
| 03-Nov-16 5:22 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Nov-16 | Option Exercise | 305,909 | $22.14 | $6,772,820.00 | 39% 792.87K to 1.1M | |
| 13-Oct-16 5:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 11-Oct-16 | Option Exercise | 368,706 | $17.51 | $6,456,040.00 | 87% 424.16K to 792.87K | |
| 04-Oct-16 5:50 PM View: | Bristol-Myers Squibb Co. (BMY) | 30-Sep-16 | Grant | 463 | $53.92 | $24,965.00 | < 1% 423.7K to 424.16K | 4% |
| 14-Sep-16 4:51 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 12-Sep-16 | Grant | 67 | $68.17 | $4,589.74 | < 1% 12.08K to 12.15K | 24% |
| 09-Sep-16 4:41 PM View: | Bristol-Myers Squibb Co. (BMY) | 08-Sep-16 | Market Sale (Planned) | 10,800 | $56.97 | $615,276.00 | (2%) 434.5K to 423.7K | 1% |
| 09-Sep-16 4:41 PM View: | Bristol-Myers Squibb Co. (BMY) | 07-Sep-16 | Market Sale (Planned) | 10,800 | $56.77 | $613,116.00 | (2%) 445.3K to 434.5K | 1% |
| 25-Aug-16 5:10 PM View: | Bristol-Myers Squibb Co. (BMY) | 25-Aug-16 | Market Sale (Planned) | 11,600 | $58.92 | $683,472.00 | (3%) 456.9K to 445.3K | 5% |
| 25-Aug-16 5:10 PM View: | Bristol-Myers Squibb Co. (BMY) | 24-Aug-16 | Market Sale (Planned) | 11,600 | $59.43 | $689,359.00 | (2%) 468.5K to 456.9K | 6% |
| 11-Jul-16 5:12 PM View: | Bristol-Myers Squibb Co. (BMY) | 08-Jul-16 | Market Sale (Planned) | 11,600 | $75.04 | $870,461.00 | (2%) 480.1K to 468.5K | 25% |
| 11-Jul-16 5:12 PM View: | Bristol-Myers Squibb Co. (BMY) | 07-Jul-16 | Market Sale (Planned) | 11,600 | $73.86 | $856,776.00 | (2%) 491.7K to 480.1K | 24% |
| 05-Jul-16 6:09 PM View: | Bristol-Myers Squibb Co. (BMY) | 30-Jun-16 | Grant | 474 | $73.55 | $34,862.70 | < 1% 491.23K to 491.7K | (24%) |
| 30-Jun-16 5:42 PM View: | Bristol-Myers Squibb Co. (BMY) | 29-Jun-16 | Market Sale (Planned) | 9,800 | $72.79 | $713,342.00 | (2%) 501.99K to 492.19K | 23% |
| 30-Jun-16 5:42 PM View: | Bristol-Myers Squibb Co. (BMY) | 28-Jun-16 | Market Sale (Planned) | 13,400 | $71.67 | $960,396.00 | (3%) 503.79K to 490.39K | 22% |
| 14-Jun-16 2:11 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 10-Jun-16 | Grant | 68 | $67.56 | $4,564.07 | < 1% 12.01K to 12.08K | 26% |
| 06-May-16 4:53 PM View: | Bristol-Myers Squibb Co. (BMY) | 05-May-16 | Market Sale | 11,600 | $70.59 | $818,844.00 | (2%) 525.19K to 513.59K | 21% |
| 06-May-16 4:53 PM View: | Bristol-Myers Squibb Co. (BMY) | 04-May-16 | Market Sale | 11,600 | $70.48 | $817,568.00 | (2%) 536.79K to 525.19K | 21% |
| 04-May-16 5:28 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-May-16 | Option Exercise | 234,720 | $26.04 | $6,112,790.00 | 44% 536.79K to 771.51K | |
| 04-May-16 5:28 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-May-16 | Market Option Sale | 234,720 | $71.88 | $16,870,800.00 | (30%) 771.51K to 536.79K | 22% |
| 29-Apr-16 4:21 PM View: | EI DuPont de Nemours & Co. (CTAPRA,B) | 27-Apr-16 | Grant | 2,230 | -- | -- | 23% 9.78K to 12.01K |